Skip to main content

Identifying Risk-Reducing Strategies for Breast Cancer and How Payers Can Address the Costs of Medications

December 09, 2020

victor vogel, MD, Geisinger Health SystemVictor G Vogel, MD, medical oncologist, Geisinger Health System, discusses a variety of risk reducing strategies for breast cancer, including why some are “overdue,” explains why there is a lack in the uptake of medications among patients despite national and global organization support for these treatments, and offers suggestions on what payers can do to help address issues relating to the cost of treatment. 


Vogel VG. Implementation of risk reducing strategies for breast cancer is long overdue [published online ahead of print, 2020 Nov 11]. Cancer Prev Res (Phila). 2020;canprevres.0556.2020. doi:10.1158/1940-6207.CAPR-20-0556

Agree or disagree with an article? Share your professional thoughts on an article you read.

Your Name
2 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Back to Top